ImaginAb, Inc. is an antibody engineering company that specializes in the development of novel and proprietary biologics technology platforms for therapeutic and diagnostic applications. The company's expertise lies in engineering small antibody formats that enable highly specific cancer targeting, rapid tumor uptake, and blood clearance, making them highly effective for imaging and treating tumors with a broad range of radioisotopes, particularly alpha emitters.